La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Fresenius Medical Care Gestione
Gestione criteri di controllo 1/4
Fresenius Medical Care's Il CEO è Helen Giza, nominato in Nov2019, e ha un mandato di 4.75 anni. la retribuzione annua totale è € 5.53M, composta da 30.1% di stipendio e 69.9% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.005% delle azioni della società, per un valore di € 471.55K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1.7 anni e 0.6 anni.
Informazioni chiave
Helen Giza
Amministratore delegato
€5.5m
Compenso totale
| Percentuale dello stipendio del CEO | 30.1% |
| Mandato del CEO | 4.8yrs |
| Proprietà del CEO | 0.005% |
| Durata media del management | 1.7yrs |
| Durata media del Consiglio di amministrazione | less than a year |
Aggiornamenti recenti sulla gestione
Recent updates
At €34.34, Is Fresenius Medical Care AG (ETR:FME) Worth Looking At Closely?
Aug 20
Fresenius Medical Care AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 02These 4 Measures Indicate That Fresenius Medical Care (ETR:FME) Is Using Debt Extensively
Jun 17What You Can Learn From Fresenius Medical Care AG's (ETR:FME) P/E
May 30Some Shareholders May Object To A Pay Rise For Fresenius Medical Care AG's (ETR:FME) CEO This Year
May 10Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19
Apr 26Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 29Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19
Mar 14Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19
Feb 23When Should You Buy Fresenius Medical Care AG (ETR:FME)?
Feb 22Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings
Feb 03Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital
Jan 16Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?
Dec 29Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?
Nov 21Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal
Oct 16Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?
Sep 28Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?
Aug 21An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued
Jul 23Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture
Jul 09These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively
Jun 25What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?
May 07Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?
Apr 23We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt
Mar 24Should You Think About Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME) Now?
Feb 03Are Investors Undervaluing Fresenius Medical Care AG & Co. KGaA (ETR:FME) By 45%?
Jan 19Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively
Jan 04Fresenius Medical Care KGaA (ETR:FME) Takes On Some Risk With Its Use Of Debt
Dec 17Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | €530m |
| Mar 31 2024 | n/a | n/a | €484m |
| Dec 31 2023 | €6m | €2m | €499m |
| Sep 30 2023 | n/a | n/a | €450m |
| Jun 30 2023 | n/a | n/a | €596m |
| Mar 31 2023 | n/a | n/a | €602m |
| Dec 31 2022 | €3m | €1m | €673m |
| Sep 30 2022 | n/a | n/a | €763m |
| Jun 30 2022 | n/a | n/a | €806m |
| Mar 31 2022 | n/a | n/a | €878m |
| Dec 31 2021 | €2m | €855k | €969m |
| Sep 30 2021 | n/a | n/a | €918m |
| Jun 30 2021 | n/a | n/a | €998m |
| Mar 31 2021 | n/a | n/a | €1b |
| Dec 31 2020 | €2m | €855k | €1b |
| Sep 30 2020 | n/a | n/a | €1b |
| Jun 30 2020 | n/a | n/a | €1b |
| Mar 31 2020 | n/a | n/a | €1b |
| Dec 31 2019 | €2m | €108k | €1b |
Compensazione vs Mercato: La retribuzione totale di Helen ($USD 6.13M ) è circa la media per le aziende di dimensioni simili nel mercato German ($USD 5.47M ).
Compensazione vs guadagni: La retribuzione di Helen è aumentata di oltre il 20%, mentre gli utili aziendali sono diminuiti di oltre il 20% nell'ultimo anno.
AMMINISTRATORE DELEGATO
Helen Giza (56 yo)
4.8yrs
Mandato
€5,528,000
Compensazione
Ms. Helen Giza is Chief Executive Officer and Chair of the Management Board of Fresenius Medical Care Management AG, General Partner of Fresenius Medical Care AG & Co. KGAA from December 6, 2022. She serve...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chair of Management Board & CEO | 4.8yrs | €5.53m | 0.0047% € 479.7k | |
| CFO & Member of the Management Board | less than a year | €887.00k | Nessun dato | |
| Global Chief Medical Officer & Member of Management Board | 4.6yrs | €3.13m | 0.0062% € 633.4k | |
| CEO of Care Enablement & Member of Management Board | 2.6yrs | €3.71m | 0.0039% € 396.6k | |
| CEO of Care Delivery & Member of Management Board | less than a year | Nessun dato | Nessun dato | |
| Executive VP and Head of Investor Relations | no data | Nessun dato | Nessun dato | |
| Global Head of Legal | less than a year | Nessun dato | Nessun dato | |
| Senior Vice President of Corporate Communications & Governmental Affairs | no data | Nessun dato | Nessun dato | |
| Senior Vice President of Research & Development | no data | Nessun dato | Nessun dato | |
| Senior Vice President of Manufacturing and Supply Chain Operations | no data | Nessun dato | Nessun dato | |
| Senior Vice President - Quality Management International | no data | Nessun dato | Nessun dato | |
| Executive Vice President of Western Europe & Nephrocare Coordination EMEALA | no data | Nessun dato | Nessun dato |
1.7yrs
Durata media
56.5yo
Età media
Gestione esperta: Il team dirigenziale di FME non è considerato esperto (durata media 1.7 anni), il che suggerisce un nuovo team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Independent Member of Supervisory Board | less than a year | €20.00k | Nessun dato | |
| Chairman of the Supervisory Board | 1.1yrs | €444.00k | Nessun dato | |
| Independent Member of Supervisory Board | less than a year | €21.00k | Nessun dato | |
| Independent Member of Supervisory Board | 3.3yrs | €151.00k | Nessun dato | |
| Employee Representative Deputy Chairwoman of the Supervisory Board | less than a year | Nessun dato | Nessun dato | |
| Member of Supervisory Board | less than a year | €158.00k | Nessun dato | |
| Employee Representative Member of Supervisory Board | less than a year | Nessun dato | Nessun dato | |
| Employee Representative Member of the Supervisory Board | less than a year | Nessun dato | Nessun dato | |
| Employee Representative Member of the Supervisory Board | less than a year | Nessun dato | Nessun dato | |
| Employee representatives Member of the Supervisory Board | less than a year | Nessun dato | Nessun dato | |
| Employee representatives Member of the Supervisory Board | less than a year | Nessun dato | Nessun dato |
0.6yrs
Durata media
56yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di FME non è considerato esperto (durata media del mandato 0.6 anni), il che suggerisce un nuovo consiglio.